Chemomab Therapeutics (CMMB)
(Delayed Data from NSDQ)
$1.71 USD
+0.03 (1.79%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $1.69 -0.02 (-1.17%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth D Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/14/2024
Time: -- |
9/2024 | $-0.20 | 0.00% |
Earnings Summary
For their last quarter, Chemomab Therapeutics (CMMB) reported earnings of -$0.26 per share, missing the Zacks Consensus Estimate of -$0.20 per share. This reflects a negative earnings surprise of 30.00%. Look out for CMMB's next earnings release expected on November 14, 2024. For the next earning release, we expect the company to report earnings of -$0.20 per share, reflecting a year-over-year increase of 41.18%.
Earnings History
Price & Consensus
Zacks News for CMMB
Chemomab Therapeutics Ltd. Sponsored ADR (CMMB) Now Trades Above Golden Cross: Time to Buy?
CMMB: What are Zacks experts saying now?
Zacks Private Portfolio Services